Hua Medicine (Shanghai) Ltd.
https://www.huamedicine.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hua Medicine (Shanghai) Ltd.
Asia Deal Watch: Takeda Will Employ Engitix’s ECM Tech In Liver Fibrosis Indications
Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.
No Love From US: Senate Bill Deals Blow To Aspiring China Biotechs
In a bipartisan move, the US Senate is moving to impose new rules on companies - including those from China - seeking US initial public offerings, adding further uncertainty over such plans and further stoking trade tensions.
Finance Watch: Erasca Raises $200m As VC Mega-Rounds Continue
Private Company Edition: In addition to Erasca’s big series B round, Mabwell reportedly brought in $278m. Also, Kurma, Venrock and Section bring the number of new VC funds in April to eight, raising $5.89bn, and former AveXis execs launched the new gene therapy venture Taysha.
New Phase II Data Bolster vTv Therapeutics’ Glucokinase Activator Aspirations
The future for glucokinase activation is looking brighter after fresh data on vTv’s oral adjunct to insulin therapy in type 1 diabetes.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals